Debasish Swain

Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor

Debasish Swain, Gananadhamu Samanthula, Shweta Bhagat et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 51 citations

Antiviral Drug, Silico Toxicity Prediction, Drug Resistance +16

Sustained-Release Curcumin Microparticles for Effective Prophylactic Treatment of Exocrine Dysfunction of Pancreas: A Preclinical Study on Cerulein-Induced Acute Pancreatitis

Pratibha Anchi, Amit Khurana, Debasish Swain et al. · Journal of Pharmaceutical Sciences · 2018 · 34 citations

Nanomedicine, Engineering, Sustained-release Curcumin Microparticles +8

LC–ESI–MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products

Chiguru Vishnuvardhan, Baikadi Saibaba, Lingesh Allakonda et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 21 citations

Major Degradation Products, Chemoprevention Strategy, Medicine +8

Study on the forced degradation behaviour of ledipasvir: Identification of major degradation products using LC–QTOF–MS/MS and NMR

Debasish Swain, Gananadhamu Samanthula · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 18 citations

Major Degradation Products, Engineering, Biochemistry +8

Dramatic improvement in pharmacokinetic and pharmacodynamic effects of sustain release curcumin microparticles demonstrated in experimental type 1 diabetes model

Pratibha Anchi, Amit Khurana, Debasish Swain et al. · European Journal of Pharmaceutical Sciences · 2019 · 18 citations

Experimental Type 1, Nanomedicine, Diabetes Management +9